Molina Healthcare (MOH) has been making headlines for various reasons.
Jim Cramer discussed the recent movement in MOH's share price. The company has secured a significant contract for
Florida Medicaid, potentially escalating its premiums to nearly $5B by 2025. However, negative news came in the form of an impending
deadline for MOH investors to secure counsel for an ongoing
securities class action. Along with this, MOH's shares have been falling, leading to reevaluation of its
valuation in light of policy shifts, lawsuits, and profit warnings.
Wells Fargo has adjusted their price target for MOH to $165. MOH has also been dealing with investigations over
earnings guidance and cost disclosures. Despite beating on revenue in the Q3, MOH's stock fell by 17.9%, due to elevated medical costs and worries about Obamacare. Furthermore, guidance cuts and ongoing legal scrutiny have added uncertainty. Nonetheless, amidst turmoil, the company remains at a value multiple showing resilience against Medicaid headwinds.
Molina Healthcare MOH News Analytics from Wed, 02 Jul 2025 07:00:00 GMT to Sat, 15 Nov 2025 00:25:38 GMT -
Rating -6
- Innovation -2
- Information 7
- Rumor -8
